DEEPGEN Trademark

Trademark Overview

On Monday, December 9, 2019, a trademark application was filed for DEEPGEN with the United States Patent and Trademark Office. The USPTO has given the DEEPGEN trademark a serial number of 88720345. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 4, 2023. This trademark is owned by Quantgene Inc.. The DEEPGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

biomedical research services; biochemical research and development; medical research services in the field of cancer; providing medical testing services and information in the field of cancer research
deepgen

General Information

Serial Number88720345
Word MarkDEEPGEN
Filing DateMonday, December 9, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkDEEP GEN
Goods and Servicesbiomedical research services; biochemical research and development; medical research services in the field of cancer; providing medical testing services and information in the field of cancer research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 12, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuantgene Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404

Trademark Events

Event DateEvent Description
Wednesday, October 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, January 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 22, 2022WITHDRAWAL OF ATTORNEY GRANTED
Friday, April 22, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, March 23, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 23, 2022FINAL REFUSAL E-MAILED
Wednesday, March 23, 2022FINAL REFUSAL WRITTEN
Wednesday, February 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 17, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 17, 2021NON-FINAL ACTION E-MAILED
Tuesday, August 17, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 28, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Wednesday, October 7, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 12, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2020LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2020SUSPENSION LETTER WRITTEN
Monday, March 9, 2020ASSIGNED TO EXAMINER
Thursday, December 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2019NEW APPLICATION ENTERED

Related Keywords

deepgen research services cancer field medical testing information providing biochemical development